Healthvista India IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 17, 2022The medical care provider, Healthvista India, has filed the Draft Red Herring Prospectus with SEBI to seek its approval and raise money through an Initial Public Offering. The IPO comprises a Fresh Issue of Equity Shares and an Offer for Sale.
Healthvista India is aiming to raise up to Rs. 1000 crores from the upcoming IPO. And before you decide to invest in Healthvista India IPO, you should gather all the necessary and important information about the company and its IPO.
Healthvista India IPO Review will help you easily find all the details in one place and in the most understandable way.
| Face Value | Rs 1 |
| Price Band | Rs.X to Rs.X |
| Listing At | BSE, NSE |
| Min. Order Quantity | Not Disclosed |
| Listing Date | Not Disclosed |
| Offer for Sale | Not Disclosed |
| Fresh Issue | Not Disclosed |
| IPO Size | Not Disclosed |
| Tick Size | 1 |
Healthvista India IPO Overview
Healthvista India IPO is a combination of a Fresh share issue aggregating up to Rs. 200 crores and an Offer for Sale for up to 56,252,644 equity shares. Some of the existing shareholders will be offloading their shareholdings in the company.
The IPO is a mainline IPO, and the shares will be listed on BSE and NSE, respectively. And SBI Capital Markets Limited, IIFL Securities Limited, and JM Financial Limited will be in the role of Book Running Lead Managers for the IPO.
Healthvista India IPO Important Dates
| Events | Date |
| IPO Opening Date | Not Disclosed |
| IPO Closing Date | Not Disclosed |
| Basis of Allotment Finalization | Not Disclosed |
| Refunds Initiation | Not Disclosed |
| Credit of Shares to Demat Account | Not Disclosed |
| Share Listing Date | Not Disclosed |
Healthvista India IPO Dates will be updated soon after the SEBI approval for DRHP. The company will arrive at the most suitable IPO dates to ensure its success in the market and receive a full subscription.
The company recently filed the preliminary documents with the capital market regulator for obtaining its nod. It is a mandatory prerequisite before offering any shares to the public at large.
Healthvista India IPO Price, Size, Share Offerings
| Face Value | Rs.1 |
| Price Band | Rs.X to Rs.X |
| Offer for Sale | Not Disclosed |
| Fresh Issue | Not Disclosed |
| IPO Size | Not Disclosed |
Healthvista India IPO Size will be formed of the equity shares offered through Fresh Issue and Offer for Sale. Healthvista India IPO Price will be discovered by the company and the selling shareholders in consultation with the Book Running Lead Managers through the Book Building Process. It will be based on the assessment of the market demand and other essential factors.
The face value of the shares is Rs. 1 each.
Healthvista India IPO Grey Market Premium
| Date | GMP (Rs.) | Kostak Rate (Rs.) | Subject to Sauda (Rs.) |
| NA | NA | NA | NA |
| NA | NA | NA | NA |
| NA | NA | NA | NA |
| NA | NA | NA | NA |
| NA | NA | NA | NA |
| NA | NA | NA | NA |
| NA | NA | NA | NA |
| NA | NA | NA | NA |
Healthvista India IPO GMP will be open after the IPO dates are declared by the company. Investors and traders rely highly on the trends of this market, and it helps them to estimate the listing price of a share on the stock exchange.
The Grey market is an unofficial market, but it holds a high weigh in the IPO proceedings. Investors bid for the IPO per the price prevailing in the grey market. The price prevailing in the grey market is called Grey Market Premium.
Healthvista India IPO Subscription Status
| Day / Date | QIB | NII | RII | Emp | Total Subscription |
| 1st Day – | |||||
| 2nd Day – | |||||
| 3rd Day – | |||||
| Shares Offered or Net Issue |
The subscription process is the real show time of an Initial Public Offering (IPO). It is the moment of truth and risk, as they say. The success of an IPO is tied to its subscription level very much. There can generally be two situations of the subscription process, i.e., Oversubscription and Undersubscription.
Every company is required to attain a 90% subscription to complete its IPO and list the securities, otherwise, the IPO cannot be completed, and the company will be required to refund the application money.
Healthvista India IPO Subscription will open after the DRHP approval, and we will update you with the right information.
Healthvista India IPO Allotment Status
The Healthvista India IPO Allotment will lead to crediting equity shares in the Demat accounts of the successful bidders. The company will determine the allotment basis and allot the shares.
The allotment of shares takes place online and does not require dispatching share certificates to the shareholders.
Healthvista India IPO Live Performance
Why wonder about the IPO Live Performance when you can stay updated with it at a single click. Know the process and the changes in the Healthvista India IPO Performance and stay updated.
Subscribe to Healthvista India IPO – Open Free Demat Account Now!
Healthvista India – Company Review
The company was registered as Healthvista India Private Limited, a private limited company, in 2013. The company got converted to a public limited company in June 2022.
Led by a strong team of experts and professional individuals, the company has achieved long miles over the years.
The company delivers quality care to its patients with compassion and professionalism. They offer healthcare and facilities to ease patients at home.
Products or Services
Healthvista India offers various services through its brand Portea – Health At Home. The company caters to the requirements of patients with Physiotherapy, Nursing, Medical Equipment, Trained Attendants, Lab Tests, Elder Care, Doctors Consultation, Diabetes Care, Counselling, Vaccination, Nutrition & Diet Consultation, Critical Care, Mother & Baby Care, and Covid Care.
They are helping patients with their services and comforting them.
Promoters and Holding
Healthvista India Limited is a professionally managed company and does not have an identifiable promoter.
The Management of Healthvista India Limited consists of:
- Meena Ganesh, in the position of Chairperson and Non-Executive Director
- Vaibhav Tewari, in the position of Chief Executive Officer and Wholetime Director
- Ganesh Krishnan, in the position of Non-Executive Director
- Barath Shankar Subramanian, in the position of Non-Executive Director
- Nandakumar Jairam, in the position of Independent Director
- Sarang Deo, in the position of Independent Director
- Subhasri Sriram, in the position of Independent Director
- Koneti Madhanbabu Aswin Kumar, in the position of Chief Financial Officer
- Vishal Sehgal, in the position of President
- G Ramasubramani, in the position of Chief Technology Officer
- Sachin Kumar Verma, in the position of Chief Delivery Officer
- Vasant Bhat, in the position of Company Secretary and Compliance Officer
Is Healthvista India good for Investment?
Healthvista India Limited is a thriving company and has made some interesting implementations with its operations. The company offers healthcare services to patients in the comfort of their homes and aims at making good healthcare services accessible. They are strongly working towards their objective.
The company’s financial history doesn’t look very good presently. They are incurring losses for the past few years.
Healthvista India Financial Statements
| Amount (in INR & Million) | ||||
| 31-Dec-21 | 31-Mar-21 | 31-Mar-20 | Mar-19 | |
| Assets | 1,014.84 | 960.12 | 976.58 | 1,223.86 |
| Revenue | 1,191.11 | 1,303.89 | 1,620.55 | 1,494.82 |
| Expense | 1,539.75 | 1,674.04 | 2,099.76 | 2,211.62 |
| Profit After Tax | (348.64) | (370.15) | (480.10) | (717.61) |
Healthvista India Limited is not in a good state when it comes to its financial state. The company has been incurring year-on-year loss.
The revenues of the company in the years 2021, 2020, and 2019 were – Rs. 1,303.89 million, Rs. 1,620.55 million, and Rs. 1,494.82 million, respectively.
The losses of the company in the years 2021, 2020, and 2019 were – Rs. (370.15) million, Rs. (480.10) million, and Rs. (717.61) million, respectively.
In the nine months of the financial year 2021-22, the total revenue of the company was Rs. 1,191.11 million and the loss incurred during the period was Rs. (348.64) million.
| Earnings per Equity Share (in Million) | ||||
| 31-Dec-21 | 31-Mar-21 | 31-Mar-20 | Mar-19 | |
| Basic & Diluted | (4.87) | (5.88) | (7.63) | (11.39) |
The Earning Per Share (EPS) of Healthvista India Limited is also in the negative shadows for the past few years. As of 31st December 2021, the EPS was Rs. (4.87).
Healthvista India IPO Review
Healthvista India IPO is a Rs. 1,000 crores IPO. The IPO will enter the floor soon with a Fresh issue of equity shares and share sale by its selling shareholders.
The selling shareholders are Accel Growth III Holdings (Mauritius) Limited, Accel India III (Mauritius) Limited, Ventureast Life Fund III LLC, MEMG CDC Ventures, Qualcomm Asia Pacific Pte Ltd, Accel India V (Mauritius) Limited, and Sabre Partners Trust. They will sell shares in different quantities and bring their holding down in the company.
As part of the IPO, the company might consider a private placement of shares for up to Rs. 40 crores before filing the Red Herring Prospectus.
The selling shareholders will receive the proceeds from the offer for sale.
The company will be utilizing the funds from the Fresh Issue towards funding the working capital requirements of its material subsidiary Medybiz Pharma Private Limited, prepaying or repaying debts of the company, purchasing medical equipments, and funding for inorganic growth strategies.
Healthvista India IPO Details
Here are few more details you need to know before investing in Healthvista India IPO –
Healthvista India IPO Issue Object
The Healthvista India has proposed diverse objectives for making the IPO offer and some of the objectives are:
- Funding the working capital requirements of our Material Subsidiary, namely Medybiz Pharma Private Limited
- Re-payment/ pre-payment of certain indebtedness availed by our Company
- Purchase of medical equipment
- Marketing and brand building activities
- Inorganic growth initiatives and general corporate purposes
Healthvista India IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Industry tailwinds – Out-of-hospital health care sector in India is expected to triple in size from $6.03 billion in 2021 to reach $15.87 billion by 2027 growing by a CAGR of 17% during 2021–2027, while organized sector will grow with 32% CAGR for same period.
- Out-of-hospital healthcare brand with largest geographical footprint and established strategic relationships in the Indian healthcare ecosystem;
- Comprehensive offerings for patients leading to customer stickiness across a lifetime journey enabling multiple revenue streams and increased wallet share;
- In-depth medical expertise and comprehensive clinical protocols to deliver quality healthcare;
- Sophisticated technology stack and digital portfolio leveraging proprietary technology to broaden range of offerings;
- Ability to attract, train and retain high-quality medical personnel;
- Stable financial performance with improved margins;
- Experienced and entrepreneurial driven leadership team.
Quantitative factors are:
| Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-21 | (5.88) | (5.39) | (32.90) |
| 31-Mar-20 | (7.63) | (7.37) | – |
| Mar-19 | (11.39) | (11.82) | – |
Healthvista India IPO Lead Managers
Here are the list of Lead managers –
- SBI Capital Markets Limited
- IIFL Securities Limited
- JM Financial Limited
Healthvista India IPO Registrar to offer
Check out the details of the registrar here –
Link Intime India Private Limited
Address – C 101, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai 400083, Maharashtra, India
Tel: +91 22 4918 6200
E-mail: Healthvista India.ipo@linkintime.co.in
Website: www.linkintime.co.in
Investor grievance E-mail: Healthvista India.ipo@linkintime.co.in
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058
Healthvista India IPO – Other Details
- Statutory Auditor – Deloitte Haskins & Sells
- Legal Counsel to the Company – IndusLaw
- Bankers to the Company – Kotak Mahindra Bank Limited
Healthvista India IPO – Conclusion
The Healthvista India IPO is the first public offer of the company. They are offering shares through Fresh issues and share sale by existing shareholders. The company will be implementing its growth initiatives and paying its debts with the proceeds of the IPO.
Investors can consider investing in the shares of the company as the operations of the company are growing, and they have a diverse range of services. Their operational sphere is widening with time.
To Subscribe to Healthvista India IPO – Open Demat Account Now!
Healthvista India IPO Review FAQs
Check out the FAQs on Healthvista India IPO –
What is the Issue Size of Healthvista India IPO?
The Company is making an initial public offer of NA equity shares. They vividly portray the aspects of the issue in this article.
You can check the stats on the fresh issue, Offer for sale, and net issue.
What is the Price band of Healthvista India IPO?
The price band for this particular IPO ranges between Rs.462 to Rs.487. As far as the face value of the share is of concern, it is Rs.1 per share.
What is the Healthvista India IPO Open Date?
The opening and closing dates for this IPO have been updated. The IPO is set to open on NA, while the closing date is set at NA.
What is the Healthvista India IPO Allotment Date?
They also have the news regarding the respective allotment dates of this IPO.
Basis of Allotment finalization is on NA, refund initiation is on NA, credit of shares is on NA, and share listing date is on NA.
What is the Healthvista India IPO Listing Date?
Shares of this company shall be listed in the exchanges NA. The date, when the listing would be done, is stagnant on NA.
Who is the Registrar of Healthvista India IPO?
One of the reputed registrars is managing the issue of this IPO, i.e. Link Intime India Private Limited. Their website will help you regarding the further information you are on the lookout for.
Who is the Promoter of Healthvista India IPO?
Here are the promoters of this IPO – PROFESSIONALLY MANAGED. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
What is the GMP of Healthvista India IPO?
They have obtained the GMP of this IPO and it is Rs. X. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Is Healthvista India IPO good for Investment?
They have further provided the financial status of the company in this article, from the past few years.
You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
What is the PAT of Healthvista India Company?
They have the information of company financials, and according to that, they have the figures from the last few years to provide.
PAT for the financial year 2021 in Million is (370.15), 2020 is (480.10), 2019 is (717.61). PAT from Dec 2021 is (348.64).
Featured Topics